Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah L Burkhart

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Nature Reviews. Cancer|July 25, 2008
Cellular mechanisms of tumour suppression by the retinoblastoma geneDeborah L Burkhart, Julien Sage
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Complex transcriptional regulatory networks around the retinoblastoma tumor suppressor geneDeborah L Burkhart, Julien Sage
Cancer Discovery|April 4, 2022
Classification of KRAS-Activating Mutations and the Implications for Therapeutic InterventionChristian Johnson, Deborah L Burkhart, Kevin M Haigis
Cell Cycle (Georgetown, Tex.)|August 23, 2008
GFP reporter mice for the retinoblastoma-related cell cycle regulator p107Deborah L Burkhart, Patrick Viatour, Victoria M Ho, et al.
Plos Genetics|June 30, 2010
Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functionsDeborah L Burkhart, Stacey E Wirt, Anne-Flore Zmoos, et al.
Advances in Experimental Medicine and Biology|January 5, 2020
The Role of RB in Prostate Cancer ProgressionDeborah L Burkhart, Katherine L Morel, Anjali V Sheahan, et al.
Journal of Lipid Research|August 6, 2020
Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancerZoe Hall, Catherine H Wilson, Deborah L Burkhart, et al.
Molecular and Cellular Biology|January 27, 2010
Regulation of RB transcription in vivo by RB family membersDeborah L Burkhart, Lynn K Ngai, Caitlin M Roake, et al.
Cancer Research|June 24, 2016
Myc Expression Drives Aberrant Lipid Metabolism in Lung CancerZoe Hall, Zsuzsanna Ament, Catherine H Wilson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Nature Reviews. Cancer|July 25, 2008
Cellular mechanisms of tumour suppression by the retinoblastoma geneDeborah L Burkhart, Julien Sage
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Complex transcriptional regulatory networks around the retinoblastoma tumor suppressor geneDeborah L Burkhart, Julien Sage
Cancer Discovery|April 4, 2022
Classification of KRAS-Activating Mutations and the Implications for Therapeutic InterventionChristian Johnson, Deborah L Burkhart, Kevin M Haigis
Cell Cycle (Georgetown, Tex.)|August 23, 2008
GFP reporter mice for the retinoblastoma-related cell cycle regulator p107Deborah L Burkhart, Patrick Viatour, Victoria M Ho, et al.
Plos Genetics|June 30, 2010
Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functionsDeborah L Burkhart, Stacey E Wirt, Anne-Flore Zmoos, et al.
Advances in Experimental Medicine and Biology|January 5, 2020
The Role of RB in Prostate Cancer ProgressionDeborah L Burkhart, Katherine L Morel, Anjali V Sheahan, et al.
Journal of Lipid Research|August 6, 2020
Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancerZoe Hall, Catherine H Wilson, Deborah L Burkhart, et al.
Molecular and Cellular Biology|January 27, 2010
Regulation of RB transcription in vivo by RB family membersDeborah L Burkhart, Lynn K Ngai, Caitlin M Roake, et al.
Cancer Research|June 24, 2016
Myc Expression Drives Aberrant Lipid Metabolism in Lung CancerZoe Hall, Zsuzsanna Ament, Catherine H Wilson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Pageof 3